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Clinical Relevance
This study provides clinicians with insight into the in vitro differences in the performance
of commercially available fluoride varnishes. More clinical research is needed to equip
dentists with evidence that will help them make better treatment choices.
SUMMARY
Most currently marketed fluoride varnishes
(FVs) have not been evaluated for their effec-
tiveness in preventing dental caries. The ob-
jective of this study was to investigate the
anticaries efficacy, measured as fluoride re-
lease into artificial saliva (AS); change in
surface microhardness of early enamel caries
lesions; and enamel fluoride uptake (EFU) of
14 commercially available FVs and two control
groups. Bovine enamel specimens (535 mm)
were prepared and assigned to 18 groups
(n=12). Early caries lesions were created in
the specimens and characterized using Vickers
microhardness (VHNlesion). FV was applied to
each group of specimens. Immediately after-
ward, specimens were incubated in 4 mL of AS
for 18 hours, which were collected and re-
newed every hour for the first six hours. AS
samples were analyzed for fluoride using an
ion-specific electrode. Specimens were then
brushed for 20 seconds with toothpaste slurry
and subjected to pH cycling consisting of a
four-hour/day acid challenge and one-minute
treatments with 1100 ppm F dentifrice for five
days. Microhardness was measured following
pH cycling (VHNpost). EFU was determined
using microbiopsy. Acid resistance (eight-hour
demin challenge) was performed after pH
cycling, and microhardness was measured
(VHNart) and compared with baseline values
to test the FV impact after pH cycling. One-way
analysis of variance was used for data analysis
(a=0.05). FVs differed in their release charac-
teristics (mean 6 SD ranged from 14.97 6 2.38
lg/mL to 0.50 6 0.15 lg/mL), rehardening capa-
bility (mean 6 SD ranged from 24.3 6 15.1 to
11.7 6 12.7), and ability to deliver fluoride to
demineralized lesions (mean 6 SD ranged from
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3303 6 789 lg/cm3 to 707 6 238 lg/cm3). Statis-
tically significant but weak linear associations
were found between DVHN(post – lesion), EFU,
and fluoride release (correlations 0.21-0.36).
The results of this study demonstrated that
differences in FV composition can affect their
efficacy in in vitro conditions.
INTRODUCTION
The effects of topically applied fluoride treatments
have been well known since the 1930s and have
resulted in beneficial outcomes in caries reduction.1-5
Several studies have confirmed the effectiveness of
fluoride varnishes (FVs) in reducing caries incidence
and prevalence with the added benefits of ease of use
and, most importantly, virtually no side effects.6-8
In vitro models are very commonly used in
cariology research. Most established models are
designed to mimic clinical conditions as closely as
possible. In vitro models have controlled scientific
settings that limit variability and increase sensitiv-
ity compared with clinical models. However, they
come with their own limitations in their inability to
fully simulate the complex intraoral environment,
especially circumstances leading to formation of
dental caries.9-11
Most of the available in vitro studies that
investigate the efficacy of FVs vary in their exper-
imental design and testing conditions.12,13 This
creates heterogeneity, making it difficult to find
benchmark tests that accurately assess efficacy.
Therefore, we have selected to investigate different
research variables that are of importance when
studying fluoride efficacy in an attempt to improve
our understanding of FVs and find the best test
conditions. We also tried to study how those
variables relate to each other in an effort to establish
relevant variables for in vitro FV research.
The aim of our study was to investigate the
potential anticaries effect of 14 commercially avail-
able FVs on artificially created early caries lesions
through the following outcome variables: 1) 24-hour
fluoride release into artificial saliva (AS), b) surface
microhardness, and c) enamel fluoride uptake




Enamel specimens, 5 3 5 mm, were obtained from
bovine teeth using a low-speed saw (IsoMet, Buehler,
Lake Bluff, IL, USA). The teeth were stored in
deionized water saturated with thymol during the
sample preparation process. The specimens were
ground and polished to create flat surfaces to
facilitate surface microhardness testing using the
Struers RotoPol 31/RotoForce 4 polishing unit
(Struers Inc, Cleveland, PA, USA). The bottom side
of the specimens was ground flat to a uniform-
thickness using 500-grit silicon carbide grinding
paper. The topside of the specimens was ground in
a series of 1200-, 2400-, and 4000-grit paper until
most of the tooth surface was flattened. The
specimens were then polished using 1-lm diamond
paste to eliminate any scratches that may have
resulted from the grinding procedure. The specimens
were sonicated in deionized water between each
grinding/polishing step. As a final cleaning step, the
polished specimens were sonicated in 2% micro-
liquid. The specimens were assessed with a magni-
fication of 103.
To be acceptable for the study, a specimen was
required to
1) have a minimum 5 3 5 mm polished facet across
the surface;
2) not have any obvious cracks or other flaws in the
enamel surface;
3) have an evenly polished, high-gloss enamel
surface; and
4) have no contamination on the top surface from
sticky wax or any other material.
Specimens were then secured, with the polished
enamel side facing upward, on a one-inch square
acrylic block using sticky wax to facilitate surface
microhardness measurements. Then, all specimen
surface areas apart from the polished top surface
were covered with a colored nail varnish (Sally
Hansen Advanced, Hard As Nails Nail Polish, Red,
New York, NY, USA). Prepared specimens were
stored at approximately 100% relative humidity and
48C until further use. A total of 216 specimens were
prepared for the present study (18 groups of 12
specimens each).
Sound Enamel Microhardness
Initial surface microhardness of the sound enamel
specimens was determined using a Vickers micro-
hardness indenter at a load of 200 g for 11 seconds
(Instron T2100B Vickers Surface Microhardness
Tester, Norwood, MA, USA). The average sound
enamel microhardness (VHNsound) was determined
from five indentations on the surface of each
specimen (Figure 1). Only specimens with 300 
VHNsound  400 were accepted into the study.
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Artificial Lesion Creation
Artificial lesions were formed in the enamel speci-
mens by a 48-hour immersion at 378C into a solution
of 0.1 M lactic acid and 0.2% Carbopol C907, which
was 50% saturated with hydroxyapatite and adjust-
ed to pH 5.0 using KOH. After demineralization, the
specimens were rinsed with deionized water for
approximately one minute. Specimens were blotted
dry with a tissue and stored at approximately 100%
relative humidity and 48C until further use.
Lesion Baseline Microhardness
Microhardness of the demineralized enamel speci-
mens was determined as described above. The
average specimen lesion baseline microhardness
(VHNlesion) was calculated. Only specimens with 25
 VHNlesion  60 were accepted into the study.
Specimens were assigned to treatment groups
(n=12) based on a randomization procedure that
resulted in treatment groups with mean VHNlesion
values that were not significantly different statisti-
cally.
Specimen Mounting
Once assigned to their treatment groups, specimens
were removed from their acrylic blocks and mounted
onto a 12-well microtiter plate lid. Acrylic blocks
(1231239 mm) were mounted onto the inside of the
lid using acrylic glue. Then, specimens were mount-
ed with the enamel side facing upward onto the
acrylic block using sticky wax.
FV Application
All products tested in this study contained 5% NaF
(22,600 ppm fluoride ion) and were assigned to
groups and labeled as per Table 1. In addition to the
test FVs shown above, two additional experimental
groups were included: one placebo group (O;
placebo varnish, no toothpaste treatment during
pH cycling phase) and one positive control group
(Oþ; no FV treatment, toothpaste treatment during
pH cycling phase). The placebo varnish had the
following composition (all w/w): 2% shellac, 10%
ethyl cellulose, 40% ethyl acetate, 2% polyvinylpyr-
rolidone, 2% xylitol, 5% NaCl, and 39% ethanol and
was manufactured in-house especially for this study.
The protective foil from the individual FV dose
was removed, and the FV was mixed using the
manufacturer’s applicator for at least 10 seconds to
homogenize the FV, as sedimentation of NaF and
phase separation may have occurred during storage.
Duraphat (group C) was supplied in a tube. For this
FV, approximately 0.5 mL was squeezed into a small
weighing cup and processed as described above. The
placebo varnish was handled in a similar manner.
Subsequently, FV was applied to the surface of
each specimen using a single brush stroke and using
the manufacturer’s applicator. Any unused FV was
discarded.
Saliva Incubation
Immediately after FV application, the lid containing
12 specimens was placed onto the microtiter plate
containing 4.0 mL of AS per well. AS had the same
composition as in a previous experiment.14 Two
batches of this solution were prepared: one for the
FV incubation phase in all specimens and one for the
pH cycling phase for all specimens.
The microtiter plate was then placed in an
incubator set at 378C. Every hour for six hours, the
lid was placed onto a new microtiter plate containing
4.0 mL fresh AS per well.
This procedure was repeated until a total AS
exposure time of six hours had been reached. After
six hours, the lid was placed onto a new microtiter
plate containing 4.0 mL AS per well, which was
placed in the incubator for 18 hours. All saliva
samples were frozen immediately after each cycle
and retained for analysis of ionic fluoride.
Figure 1. Enamel specimen (535 mm) with microhardness indenta-
tions and microdrill holes.
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Then, a soft toothbrush (Oral B P40, Procter &
Gamble, Mason, OH, USA) was used to brush each
specimen by hand. A slurry of Crest Cavity Protec-
tion (0.243% sodium fluoride; Procter & Gamble) at a
ratio of 1:2 w/w (dentifrice: AS) was prepared in a
beaker with a magnetic stirrer. The toothbrush was
dipped into the slurry briefly (approximately two
seconds). Each specimen was then brushed under a
stream of deionized water for 20 seconds, with the
specimen being rinsed another 10 seconds after
brushing. This procedure was repeated until all
specimens on the lid were brushed. A new tooth-
brush and slurry was used for each lid. After this
procedure, the pH cycling phase commenced on the
same day.
pH Cycling Phase: Remineralization
The present study was separated into three phases,
and each phase contained a placebo group (ie, O-a,
O-b, O-c) to allow for comparisons between phases.
The daily cyclic treatment regimen for each lid
containing the specimens consisted of one, one-
minute treatment period with a slurry of aforemen-
tioned toothpaste (prepared as described above),
followed by a two-hour exposure to AS, four hours
per day acid challenge in the lesion-forming solution,
and exposure to AS for the remainder of the day and
overnight. One slurry per day was prepared and
pipetted into each well of the used microtiter plates.
The pH cycling was performed by placing the lid
containing the specimens onto different microtiter
plates containing 4.0 mL each per well of toothpaste
slurry, AS, or lesion-forming solution. After each
treatment, the specimens were rinsed under running
deionized water briefly (approximately two seconds
per specimen). The regimen was repeated for five
days. The study was conducted at room temperature.
After completion of the pH cycling phase, all
specimens were carefully removed from the lids
and remounted onto an acrylic block to facilitate
microhardness and EFU measurements.
Posttreatment Microhardness
The average specimen microhardness (VHNpost) was
determined again in the same manner as when
obtaining lesion and baseline microhardness.
Enamel Fluoride Uptake
The fluoride content of the enamel specimens was
determined using the microdrill technique. The
enamel specimens were mounted perpendicular to
the long axis of a micro end mill attached to a
specially designed microdrill and drilled to a depth of
100 lm through the entire lesion. The drilling and
sample collection were performed in a static-con-
trolled atmosphere to prevent loss of enamel powder
due to charging effects. The enamel powder sample
was transferred to a diffusion dish and then
analyzed for fluoride. The diameter of the drill hole
was determined using a calibrated microscope
interfaced with an image analysis system. Indenta-
tions for microhardness testing and microdrill holes
were placed on enamel specimens according to
Figure 1.
Table 1: Study Test Products
Group Product Manufacturer Noteworthy Ingredient
A CavityShield 5% Varnish 3M ESPE —
B Vanish 5% NaF Varnish w/TCP 3M ESPE Functionalized tricalcium phosphate (fTCP), Xylitol
C Colgate Duraphat Varnish Colgate Oral Pharmaceuticals —
D Colgate Prevident Varnish Colgate Oral Pharmaceuticals Xylitol
E Sparkle V Varnish Crosstex International Xylitol
F Nupro 5% Fluoride Varnish Dentsply Professional Division —
G Kolorz Clearshield Varnish DMG America Xylitol
H MI Varnish GC America Casein phosphopeptide-ACP (CPP-ACP, Recaldent)
I Duraflor Halo 5% Sodium Fluoride Varnish Medicom —
J Enamel Pro Varnish Clear Premier Dental Amorphous calcium phosphate (ACP), Xylitol
K Vella Fluoride Varnish Preventive Technologies Xylitol
L Butler White Fluoride Varnish Sunstar Americas, Inc Xylitol
M Flor-Opal Varnish White Fluoride Varnish Ultradent Xylitol
N Waterpik UltraThin Varnish Waterpik Technologies Inc Xylitol
O Placebo Varnish (manufactured in-house) —
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Acid Resistance Test
To test whether the various FVs impart acid
resistance to the enamel specimens after pH cycling,
a second in vitro demineralization treatment was
performed and followed the same protocol as de-
scribed above but using a demineralization time of
only eight hours. The average specimen microhard-
ness (VHNart) was determined again as described
above.
AS Fluoride Analysis
The collected, frozen AS samples were thawed. An
aliquot was removed and analyzed for fluoride by
comparison to a similarly prepared standard curve
using an ion-selective electrode (Model 9609BNWP,
Orion Research, Boston, MA, USA) and meter.
Individual as well as cumulative F release data were
calculated to determine [F]max (highest F concentra-
tion found in any collected AS sample over the 24-
hour period) as well as Ftotal (the total amount of F
released from FV).
Statistical Analysis
A one-way analysis of variance statistical method
was used for data analysis. An overall significance
of (a=0.05) was used. Pairwise comparisons be-
tween the groups were conducted using Tukey’s
method. Pearson correlation coefficients were cal-
culated to investigate associations between the
study variables.
RESULTS
Specimens treated with Nupro had the highest
DVHN(post – lesion), ranging from 24.3 for Nupro to
11.7 for Vella for the specimens receiving active
treatment (Figure 2). No significant differences were
found among FV; however, Nupro was the only FV
significantly different from all placebo varnishes.
Specimens treated with Sparkle had the highest
rehardening values following the second acid chal-
lenge, DVHN(art – lesion), but were significantly
different only from those treated with Vella. All
other FVs did not statistically affect lesion rehar-
dening differently, but all FVs were significantly
different from the placebo varnishes (Figure 3).
Fluoride release trends were somewhat similar
for all tested FVs (Figure 4). The highest release for
most FVs was within the first hour of testing, and
then varnishes exhibited a steady decrease in
fluoride release over time. MI released significantly
more fluoride in the first hour than all the other
test products (9.71 lg/mL). Enamel Pro came
second (5.44 lg/mL), followed by Flor Opal (4.37
lg/mL); however, the latter two were not statisti-
cally different from each other. Flor Opal released
in the first hour of the experiment approximately
half that of MI. Butler White released significantly
less fluoride (0.12 lg/mL) in the first hour than all
other test products. Vella and Kolorz demonstrated
atypical release behavior where peak release
occurred at the five-hour collection point (2.55 lg/
mL).
For fluoride release total (Ftotal), MI released
significantly more fluoride over the 24-hour incuba-
tion period of the experiment (Ftotal=14.97 lg/mL)
than all other FVs (Table 2). In addition, Enamel Pro
and Flor Opal released more fluoride than the
remaining FVs, except Nupro. Butler White released
significantly less fluoride (Ftotal=0.50 lg/mL) than
all other FVs.
The highest concentration of fluoride at any given
time point was for MI ([F]max=9.71), which was
significantly higher than all FVs except for Enamel
Pro ([F]max=5.44), with Enamel Pro and Flor Opal
having higher peak concentrations than all remain-
ing FVs. Butler White exhibited the lowest peak
concentration ([F]max=0.17) and was significantly
lower than all other FVs under study (Table 2).
Differences between FVs were less prominent for
EFU than for Ftotal. PreviDent, Duraphat, and
Vanish had significantly higher EFU than Cavity
Shield, MI, Flor Opal, and Butler White but were not
significantly different from the other FVs (Figure 5).
There were statistically significant but weak
linear associations between DVHN(post – lesion) and
EFU (r=0.36; p,0.0001), DVHN(post – lesion) and Ftotal
(r=0.22; p=0.0011), and Ftotal and EFU (r=0.21;
p=0.0022).
DISCUSSION
In this in vitro study, we aimed to investigate the
efficacy of 14 commercially available FVs using the
same outcome variables from one of our previous in
vitro investigations.14 While the two studies inves-
tigated the effect of FVs on caries lesions, the study
models were fundamentally different. The wide
variation in performance of FV in our first experi-
ment prompted the design of this in vitro study. We
aspired to have a better understating of how
different formulations affect the efficacy of FVs.
Therefore, in this experiment, we aimed to investi-
gate a larger variety of FVs in an attempt to have a
range of products that represent different formula-
tions. Also, in this study, FVs were left on the
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Figure 2. Mean change in surface
microhardness (DVHN(post – lesion)) as
a function of fluoride varnish treat-
ment. Significant differences between
varnishes are highlighted by different
letters. Error bars denote standard
deviations.
Figure 3. Mean change in surface
microhardness (DVHN(art – lesion)) as a
function of fluoride varnish treatment.
Significant differences between var-
nishes are highlighted by different
letters. Error bars denote standard
deviations.
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specimens for a prolonged period of 24 hours versus
the six-hour period of the first study to better
simulate the clinical situation.
This in vitro experiment’s results for DVHN(post –
lesion) and for DVHN(art – lesion) were unanticipated.
As there are numerical differences in lesion rehar-
dening values from different FVs, most of the FVs
did not statistically differ from each other. Unfortu-
nately, it is hard to thoroughly interpret the results
because of the lack of detailed information on
different FV formulations. However, there seems to
be a superior effect on lesion rehardening when
Figure 4. Mean hourly fluoride re-
lease from fluoride varnishes into
saliva.
Figure 5. Enamel fluoride uptake
(EFU) as a function of fluoride varnish
treatment. Different letters highlight
significant differences between var-
nishes. Error bars denote standard
deviations.
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calcium- and phosphate-containing ingredients are
added to the formulation. This is in agreement with
our previous in vitro study.14 This may be attributed
to the abundant amount of calcium and phosphate
from these formulations that is readily available to
interact with the teeth. It is important to note that
the enhanced rehardening effect from calcium- and
phosphate-containing ingredients did not withstand
the second acid challenge. This is in contrast to a
recent systematic review that suggested a possible
long-term effect (.three months) of casein phos-
phopeptide–ACP (CPP-ACP) complexes on early
caries lesions; however, the results cannot be
extrapolated as the review investigated CPP-ACP
alone because of insufficient evidence on the
complex’s synergistic effect with fluoride.15 Another
noteworthy finding is that lesions treated with
Vanish, an FV-containing functionalized tricalcium
phosphate (fTCP), had a higher DVHN(post – lesion)
than those treated with FVs containing ACP and
CPP-ACP. This may be due to the protective effect
of functionalization of the TCP molecule that
prevents premature interaction between calcium
and fluoride and aids in remineralization in a
manner similar to that of fluoride.16
The fluoride release data in our experiment are in
agreement with our previously mentioned in-house
experiment and the 2014 study by Cochrane and
others.12,13 Calcium-containing FVs, with the excep-
tion of fTCP-containing varnishes, were able to
release significantly higher levels of fluoride into
saliva. This suggests a synergistic effect of adding
casein complexes to FVs on fluoride release and may
be explained by the bioavailable nature of ACP and
CPP-ACP compared with the less-soluble fTCP.16-18
EFU data from this study extend our results from
our aforementioned in vitro investigation. Once
again, a CPP-ACP–containing varnish delivered less
fluoride into caries lesions. This may be a result of
the negative impact that inorganic phosphate re-
leased from CPP-ACP varnishes has on the forma-
tion of CaF2, thus reducing bioavailable fluoride.
Vanish, an FV-containing fTCP, delivered more
fluoride into lesions compared with CPP-ACP and
ACP-containing FV despite its low fluoride release
into saliva. This is in agreement with a study that
compared EFU from two varnishes, one containing
fTCP and the other containing CPP-ACP.17 Also,
another study compared EFU with and without
fTCP. It was found that lesions exposed to fluoride in
conjunction with fTCP had significantly higher
fluoride uptake than those exposed to fluoride alone,
and the effect of fTCP was dose dependent. The
mechanism of action of fTCP on enhancing lesion
uptake of fluoride is not fully understood but may be
attributed to the ability of fTCP to promote fluoride-
based nucleation.16
Table 2: Cumulative Fluoride Release and Peak Fluoride Concentration (n=12)a
Fluoride Varnish Cumulative Fluoride Release [lg/mL], Mean (SD) Peak Fluoride Concentration [lg/mL], Mean (SD)
MI 14.97 (2.38) A 9.71 (1.40) A
Enamel Pro 9.20 (1.71) B 5.44 (1.05) A,B
Flor Opal 8.20 (1.91) B 4.37 (0.85) B
Nupro 6.96 (1.26) B,C 1.69 (0.43) C,D
Vella 4.91 (2.02) C,D 2.57 (2.17) C
Waterpik 3.07 (0.81) D,E 0.93 (0.30) D,E
Kolorz 2.91 (0.46) D,E 1.00 (0.11) C,D,E
PreviDent 2.82 (0.59) E,F 0.98 (0.09) C,D,E
Duraphat 2.64 (0.53) E,F 0.97 (0.12) C,D,E
Vanish 2.63 (0.53) E,F 1.28 (0.09) C,D,E
Sparkle 2.19 (0.47) E,F 0.95 (0.15) C,D,E
O-a 2.15 (0.56) E,F 1.20 (0.30) C,D,E
CavityShield 1.97 (0.14) E,F 1.28 (0.11) C,D,E
Duraflor Halo 1.82 (0.54) F 0.70 (0.22) E
O-b 0.85 (0.17) G 0.71 (0.16) E
O-c 0.81 (0.55) G,H,I 0.55 (0.51) F
Butler White 0.50 (0.15) H,I 0.17 (0.09) H
Oþ 0.49 (0.16) I 0.37 (0.16) G
a Significant differences between varnishes are highlighted by different letters.
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Contrary to our findings in our preceding in vitro
study, we were able to demonstrate a significant but
weak linear association between DVHN(post – lesion)
and EFU. To the best of our knowledge, this is the
first time an association was established between
DVHN and EFU in FV research. We are also in
agreement with another study in the lack of
meaningful correlation between fluoride release
and EFU.19 Based on our findings, we believe that
fluoride release cannot be used as a predictive
measure for EFU, and therefore, one should be
careful in relating fluoride release to FV efficacy.
While our findings are in agreement with some
studies and in disagreement with others, it is
important to remember that all FV in vitro models
have their limitations to the extent that the in vivo
situation cannot be mimicked because of the com-
plexity of in vivo caries. With FV in particular, there
is the issue of infrequent applications, which makes
modeling much harder. In our model, we tried to
mimic the in vivo application more closely. Most
other models measure only the direct effect of an FV
treatment while ignoring the effect of topical
fluorides applied between FV applications. This
makes our study more clinically relevant but also
more challenging, as there are competing effects of
the topical fluorides.
CONCLUSION
The results of this study demonstrated variation in
FV efficacy in in vitro conditions, most likely because
of differences in composition. Further investigations
are needed to develop models that will help us
understand FV behavior.
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